nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association of economic insecurities with patient-reported outcomes in systemic lupus erythematosus
|
Valle, Ana |
|
|
6 |
2 |
p. e68-e70 |
artikel |
2 |
Cardiac myxoma mimicking a spondyloarthritis flare
|
Delmotte, Anastasia |
|
|
6 |
2 |
p. e128 |
artikel |
3 |
Economic insecurities and patient-reported outcomes in patients with systemic lupus erythematosus in the USA: a cross-sectional analysis of data from the California Lupus Epidemiology Study
|
Sandoval-Heglund, Donavon |
|
|
6 |
2 |
p. e105-e114 |
artikel |
4 |
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
|
Abhishek, Abhishek |
|
|
6 |
2 |
p. e92-e104 |
artikel |
5 |
Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial
|
Redl, Anna |
|
|
6 |
2 |
p. e81-e91 |
artikel |
6 |
Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study
|
Garcia-Montoya, Leticia |
|
|
6 |
2 |
p. e72-e80 |
artikel |
7 |
Idiopathic inflammatory myopathies: current insights and future frontiers
|
Connolly, Caoilfhionn M |
|
|
6 |
2 |
p. e115-e127 |
artikel |
8 |
Improving COVID-19 vaccine response in individuals receiving methotrexate
|
Bechman, Katie |
|
|
6 |
2 |
p. e67-e68 |
artikel |
9 |
Pandemic to endemic: optimising COVID-19 immunity
|
The Lancet Rheumatology, |
|
|
6 |
2 |
p. e63 |
artikel |
10 |
Research in Brief
|
Thorley, Jennifer |
|
|
6 |
2 |
p. e71 |
artikel |
11 |
Subclinical synovitis: let's discuss prognosis before treatment
|
Yalcin-Mutlu, Melek |
|
|
6 |
2 |
p. e64-e65 |
artikel |
12 |
Targeting mTOR in sarcoid granulomas: where the rubber meets the road
|
Morgenthau, Adam S |
|
|
6 |
2 |
p. e65-e66 |
artikel |